113 related articles for article (PubMed ID: 10349299)
1. [Inhibitors in calcium oxalate crystals].
Suzuki K
Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):411-20. PubMed ID: 10349299
[No Abstract] [Full Text] [Related]
2. Glycosaminoglycans, proteins, and stone formation: adult themes and child's play.
Ryall RL
Pediatr Nephrol; 1996 Oct; 10(5):656-66. PubMed ID: 8897580
[TBL] [Abstract][Full Text] [Related]
3. The role of osteopontin on calcium oxalate crystal formation.
Konya E; Umekawa T; Iguchi M; Kurita T
Eur Urol; 2003 May; 43(5):564-71. PubMed ID: 12706004
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins.
Grover PK; Moritz RL; Simpson RJ; Ryall RL
Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin inhibits nucleation of calcium oxalate crystals.
Worcester EM; Beshensky AM
Ann N Y Acad Sci; 1995 Apr; 760():375-7. PubMed ID: 7785921
[No Abstract] [Full Text] [Related]
6. Physico-chemical aspects of calcium stone formation.
Baumann JM
Urol Res; 1990; 18 Suppl 1():S25-30. PubMed ID: 1963243
[No Abstract] [Full Text] [Related]
7. Exclusion mapping of major crystallization inhibitors in idiopathic calcium urolithiasis.
Cailhier JF; Petrucci M; Valiquette L; Guay G; Ouimet D; Bonnardeaux A
J Urol; 2001 Oct; 166(4):1484-6. PubMed ID: 11547117
[TBL] [Abstract][Full Text] [Related]
8. Role of Tamm-Horsfall protein and uromodulin in calcium oxalate crystallization.
Carvalho M; Mulinari RA; Nakagawa Y
Braz J Med Biol Res; 2002 Oct; 35(10):1165-72. PubMed ID: 12424489
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin in urinary stone formation.
Hoyer JR; Otvos L; Urge L
Ann N Y Acad Sci; 1995 Apr; 760():257-65. PubMed ID: 7785900
[No Abstract] [Full Text] [Related]
10. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
11. Tamm-Horsfall protein is a critical renal defense factor protecting against calcium oxalate crystal formation.
Mo L; Huang HY; Zhu XH; Shapiro E; Hasty DL; Wu XR
Kidney Int; 2004 Sep; 66(3):1159-66. PubMed ID: 15327412
[TBL] [Abstract][Full Text] [Related]
12. On the possible role of glycosaminoglycans as natural inhibitors of calcium oxalate stones.
Sallis JD; Lumley MF
Invest Urol; 1979 Jan; 16(4):296-9. PubMed ID: 429124
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors within the nephron.
Coe FL; Nakagawa Y; Parks JH
Am J Kidney Dis; 1991 Apr; 17(4):407-13. PubMed ID: 2008908
[TBL] [Abstract][Full Text] [Related]
14. [Structural characteristics of osteopontin for calcium oxalate crystal].
Umekawa T
Nihon Hinyokika Gakkai Zasshi; 1999 Mar; 90(3):436-44. PubMed ID: 10349302
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic urinary stone disease: possible polygenic aetiological factors.
Watts RW
QJM; 2005 Apr; 98(4):241-6. PubMed ID: 15781479
[No Abstract] [Full Text] [Related]
16. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
Suzuki K; Mayne K; Doyle IR; Ryall RL
Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
[TBL] [Abstract][Full Text] [Related]
17. Contribution of human uropontin to inhibition of calcium oxalate crystallization.
Asplin JR; Arsenault D; Parks JH; Coe FL; Hoyer JR
Kidney Int; 1998 Jan; 53(1):194-9. PubMed ID: 9453018
[TBL] [Abstract][Full Text] [Related]
18. Zeta potential distribution on calcium oxalate crystal and Tamm-Horsfall protein surface analyzed with Doppler electrophoretic light scattering.
Boevé ER; Cao LC; De Bruijn WC; Robertson WG; Romijn JC; Schröder FH
J Urol; 1994 Aug; 152(2 Pt 1):531-6. PubMed ID: 8015107
[TBL] [Abstract][Full Text] [Related]
19. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
[TBL] [Abstract][Full Text] [Related]
20. Protein inhibitors of crystallization.
Coe FI; Parks JH; Nakagawa Y
Semin Nephrol; 1991 Mar; 11(2):98-109. PubMed ID: 2034929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
